Latest News about VIR
Recent news which mentions VIR
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 21, 2021
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
December 21, 2021
From Benzinga
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
Why Vir Biotechnology Stock Surged Today
December 15, 2021
From Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 15, 2021
From Benzinga
Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb
December 15, 2021
From Benzinga
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
From Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
From Benzinga
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
From Benzinga
54 Biggest Movers From Yesterday
December 08, 2021
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
December 07, 2021
From Benzinga
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
From MarketWatch
Investors Do A Little Holiday Value Shopping On Monday
December 07, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 07, 2021
From Benzinga
22 Stocks Moving in Tuesday's Pre-Market Session
December 07, 2021
From Benzinga
From Benzinga
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
December 03, 2021
From Benzinga
White House plans at-home COVID-19 testing blitz for winter, and Germany to lock down its unvaccinated
December 02, 2021
From MarketWatch
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
From Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
From Benzinga
From InvestorPlace
27 Stocks Moving in Thursday's Pre-Market Session
December 02, 2021
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.